Abstract
The incidence of invasive pneumococcal disease in children has drastically decreased since the introduction of the 7-valent pneumococcal conjugate vaccine in the United States in 2000. However, epidemiology studies are now finding that non-vaccine serotypes are emerging and are associated with multidrug resistance. Specifically, the incidence of the non-vaccine serotype 19A causing invasive pneumococcal disease has increased over the past few years. Several studies from various areas of the United States report changes in serotypes and antimicrobial resistance associated with Streptococcus pneumoniae causing invasive disease, such as meningitis, bacteremia, and pneumonia. Evidence regarding the 19A isolate emergence in otitis media and mastoiditis is now being identified and detailed. Practitioners must be aware of this evolving pneumococcal organism and the potential clinical impact in children.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
